Tuberculosis Trial, Recruiting (NCT06893757)

Tuberculosis Trial, Recruiting NCT06893757 Sponsor: ANRS, Emerging Infectious Diseases Condition: Tuberculosis

Printed from Voxsanity (voxsanity.com.au) — NCT06893757 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Tuberculosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years old or older.
You have been diagnosed with tuberculosis (TB) — either confirmed by lab tests or assessed by a doctor based on symptoms or tissue examination — and have been receiving treatment for fewer than 8 days.
You have signed a voluntary, informed, and written consent form before taking part; if you have TB affecting the brain (tuberculous meningitis) or another serious form of TB that affects your awareness or ability to think clearly, a family member or close person may give consent on your behalf until you are able to do so yourself.

Who may not be able to join:

You have a significant difficulty with thinking, memory, or understanding that the trial team believes would stop you from reliably agreeing to take part — unless your condition is specifically TB affecting the brain (tuberculous meningitis), in which case this may still be considered (confirm with trial site).

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 20 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Nathalie DE CASTRO, MD PHD, Hôpital Saint Louis Paris

Phone: +33 5 57 57 17 67

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06893757

Sponsor: ANRS, Emerging Infectious Diseases

Phase: Not Applicable

Status: Recruiting

Condition: Tuberculosis

Trial contact: +33 5 57 57 17 67

More information: https://clinicaltrials.gov/study/NCT06893757

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years old or older.
You have been diagnosed with tuberculosis (TB) — either confirmed by lab tests or assessed by a doctor based on symptoms or tissue examination — and have been receiving treatment for fewer than 8 days.
You have signed a voluntary, informed, and written consent form before taking part; if you have TB affecting the brain (tuberculous meningitis) or another serious form of TB that affects your awareness or ability to think clearly, a family member or close person may give consent on your behalf until you are able to do so yourself.

Who may not be able to join:

You have a significant difficulty with thinking, memory, or understanding that the trial team believes would stop you from reliably agreeing to take part — unless your condition is specifically TB affecting the brain (tuberculous meningitis), in which case this may still be considered (confirm with trial site).

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 20 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

ANRS, Emerging Infectious Diseases

Registry

ClinicalTrials.gov

Start date

6 May 2026

Est. completion

1 June 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Proportion of participants with successful anti-tuberculosis treatment outcome, defined as definite or probable cure, by Month 12; Success of the anti-tuberculosis treatment

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov